Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease
Completed
Alzheimer's Association
Phase 2
1999-09-01
The goal of this study is to examine whether the administration of estrogen to
post-menopausal women and women with mild to moderate Alzheimer's disease will enhance their
memory and their capacity for learning.
Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease
Completed
Eisai Inc.
Phase 2
1999-09-01
The goal of this study is to examine whether the administration of estrogen to
post-menopausal women and women with mild to moderate Alzheimer's disease will enhance their
memory and their capacity for learning.
Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease
Completed
Pfizer
Phase 2
1999-09-01
The goal of this study is to examine whether the administration of estrogen to
post-menopausal women and women with mild to moderate Alzheimer's disease will enhance their
memory and their capacity for learning.
Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease
Completed
National Center for Research Resources (NCRR)
Phase 2
1999-09-01
The goal of this study is to examine whether the administration of estrogen to
post-menopausal women and women with mild to moderate Alzheimer's disease will enhance their
memory and their capacity for learning.
Cholinergic Modulation of Condition and Emotion in Mood Disorders: Functional Neuroimaging Studies
Terminated
National Institute of Mental Health (NIMH)
Phase 2
2003-02-27
This study looks at the role of a specific brain chemical system in the mood and attention
symptoms seen in major depression and bipolar disorders using functional brain imaging.
Caffeine in the Prevention of Post-operative Nausea and Vomiting
Completed
Beth Israel Deaconess Medical Center
N/A
2005-03-01
The objective of this study is to determine if caffeine 500 mg intravenously is efficacious
when added to standard anti-emetic prophylaxis in the prevention of post-operative nausea and
vomiting (PONV) in patients undergoing ambulatory surgery under general anesthesia.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
